237 related articles for article (PubMed ID: 3902199)
1. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
Kish JA; Ensley JF; Jacobs J; Weaver A; Cummings G; Al-Sarraf M
Cancer; 1985 Dec; 56(12):2740-4. PubMed ID: 3902199
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck.
Kish JA; Weaver A; Jacobs J; Cummings G; Al-Sarraf M
Cancer; 1984 May; 53(9):1819-24. PubMed ID: 6538456
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
Hussain M; Benedetti J; Smith RE; Rodriguez GI; Schuller D; Ensley J
Cancer; 1995 Oct; 76(7):1233-7. PubMed ID: 8630903
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM
Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
[TBL] [Abstract][Full Text] [Related]
6. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP
Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
[TBL] [Abstract][Full Text] [Related]
9. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
11. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.
De Andrés L; Brunet J; López-Pousa A; Burgués J; Vega M; Tabernero JM; Mesía R; López JJ
J Clin Oncol; 1995 Jun; 13(6):1493-500. PubMed ID: 7751897
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma.
Perey L; Pasche P; Bauer J; Capasso P; Savary M; Leyvraz S
Am J Clin Oncol; 1991 Apr; 14(2):162-5. PubMed ID: 2028924
[TBL] [Abstract][Full Text] [Related]
15. Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma.
Choksi AJ; Hong WK; Dimery IW; James P; Guillamondegui OM; Byers RM
Cancer; 1988 Mar; 61(5):909-12. PubMed ID: 3338056
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
[TBL] [Abstract][Full Text] [Related]
17. Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients.
Jelić S; Stamatović Lj; Vucićević S; Petrović Z; Kreacić M; Babović N; Jovanović N; Mikić A; Gavrilović D
Eur J Cancer; 2002 Jul; 38(11):1478-89. PubMed ID: 12110494
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
[TBL] [Abstract][Full Text] [Related]
19. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.
Rooney M; Kish J; Jacobs J; Kinzie J; Weaver A; Crissman J; Al-Sarraf M
Cancer; 1985 Mar; 55(5):1123-8. PubMed ID: 4038469
[TBL] [Abstract][Full Text] [Related]
20. An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.
Ensley J; Kish J; Tapazoglou E; Jacobs J; Weaver A; Atkinson D; Ahmed K; Mathog R; Al-Sarraf M
J Clin Oncol; 1988 Jul; 6(7):1147-53. PubMed ID: 3292714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
